Table 2.
Cumulative score | 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | Median, mo |
0 | 93 | 79 | 72 | 60 | 60 | 74 |
1 | 91 | 76 | 66 | 54 | 44 | 51 |
2 | 89 | 73 | 60 | 51 | 40 | 47 |
3 | 86 | 67 | 42 | 25 | 20 | 33 |
4 | 70 | 45 | 38 | 29 | 25 | 20 |
5 | 71 | 45 | 27 | 14 | 14 | 22 |
Prognostic factor | Score 0 | Score 0 | Score 0 | Score 1 | Score 1 | Score 1 |
Node-positive primary | negative | negative | negative | positive | positive | positive |
Disease-free interval | ≥ 12 mo | ≥ 12 mo | ≥ 12 mo | < 12 mo | < 12 mo | < 12 mo |
Number of liver metastases | 1 | 1 | 1 | > 1 | > 1 | > 1 |
Size of major liver metastases | ≤ 5 cm | ≤ 5 cm | ≤ 5 cm | > 5 cm | > 5 cm | > 5 cm |
CEA (ng/mL) | < 200 ng/mL | < 200 ng/mL | < 200 ng/mL | > 200 ng/mL | > 200 ng/mL | > 200 ng/mL |
CEA: Carcinoembryonic antigen.